title: Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction.
abstract: Adult human bone marrow-derived stem cells, having the ability to differentiate into cells of multiple lineages, have been isolated and propagated by varied protocols, including positive (CD105(+))/negative (CD45(-)GlyA(-)) selection with immunomagnetic beads, or direct plating into selective culture media. Each substratum-adherent cell population was subjected to a systematic analysis of their cell surface markers and differentiation potential. In the initial stages of culture, each cell population proliferated slowly, reaching confluence in 10-14 days. Adherent cells proliferated at similar rates whether cultured in serum-free medium supplemented with basic fibroblast growth factor, medium containing 2% fetal bovine serum (FBS) supplemented with epidermal growth factor and platelet-derived growth factor, or medium containing 10% FBS alone. Cell surface marker analysis revealed that more than 95% of the cells were positive for CD105/endoglin, a putative mesenchymal stem cell marker, and negative for CD34, CD31, and CD133, markers of hematopoietic, endothelial, and neural stem cells, respectively, regardless of cell isolation and propagation method. CD44 expression was variable, apparently dependent on serum concentration. Functional similarity of the stem cell populations was also observed, with each different cell population expressing the cell type-specific markers beta-tubulin, type II collagen, and desmin, and demonstrating endothelial tube formation when cultured under conditions favoring neural, cartilage, muscle, and endothelial cell differentiation, respectively. On the basis of these data, adult human bone marrow-derived stem cells cultured in adherent monolayer are virtually indistinguishable, both physically and functionally, regardless of the method of isolation or proliferative expansion.
authors.affiliation: Department of Stem Cell Biology Research, Genzyme Corporation, One Mountain Road, Framingham, MA 01701-9322, USA.
authors.forename: Tracey A
authors.initials: TA
authors.lastname: Lodie
authors.forename: Courtney E
authors.initials: CE
authors.lastname: Blickarz
authors.forename: Tara J
authors.initials: TJ
authors.lastname: Devarakonda
authors.forename: Chufa
authors.initials: C
authors.lastname: He
authors.forename: Ajeeta B
authors.initials: AB
authors.lastname: Dash
authors.forename: Jennifer
authors.initials: J
authors.lastname: Clarke
authors.forename: Kristen
authors.initials: K
authors.lastname: Gleneck
authors.forename: Lamya
authors.initials: L
authors.lastname: Shihabuddin
authors.forename: Ross
authors.initials: R
authors.lastname: Tubo
mesh_terms: D000328:Adult; D001854:Bone Marrow Cells / Q000145:classification / Q000502:physiology; D002356:Cartilage / Q000502:physiology; D018929:Cell Culture Techniques / Q000379:methods; D002454:Cell Differentiation; D019902:Chondrocytes / Q000166:cytology; D024043:Collagen Type II / Q000502:physiology; D006801:Humans; D008858:Microscopy, Phase-Contrast; D039902:Multipotent Stem Cells / Q000166:cytology* / Q000502:physiology*; D009474:Neurons / Q000502:physiology
chemical_list: D024043:Collagen Type II